Compass Therapeutics, Inc.
CMPX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001738021
In the last 90 days, Compass Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $363.4M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Compass Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 108
- +17 vs. Q4 2024
- Shares held
- 108.5M
- +7.40M (+7.3%) vs. Q4 2024
- Total value
- $206.1M
- +$59.5M (+40.6%) vs. Q4 2024
- New holders
- 27
- 30 more added
- Sold out
- 10
- 29 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CMPX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 215 | $363.4M |
| Q1 2026 | 201 | $921.3M |
| Q4 2025 | 173 | $881.5M |
| Q3 2025 | 125 | $528.7M |
| Q2 2025 | 103 | $281.5M |
| Q1 2025 | 108 | $206.1M |
| Q4 2024 | 92 | $147.0M |
| Q3 2024 | 79 | $169.6M |
| Q2 2024 | 82 | $93.4M |
| Q1 2024 | 78 | $187.2M |
| Q4 2023 | 77 | $134.3M |
| Q3 2023 | 76 | $176.7M |
| Q2 2023 | 73 | $287.7M |
| Q1 2023 | 73 | $266.5M |
| Q4 2022 | 55 | $401.4M |
| Q3 2022 | 38 | $145.6M |
| Q2 2022 | 34 | $163.9M |
| Q1 2022 | 34 | $85.4M |
| Q4 2021 | 37 | $201.6M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Compass Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nisa Investment Advisors, LLC | 848 | $1.61K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 354 | $673 | 0.00% | −54−13.2% | Reduced |
| Marshall & Sterling Wealth Advisors Inc. | 200 | $380 | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 193 | $367 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 65 | $124 | 0.00% | +65 | New |
| EverSource Wealth Advisors, LLC | 21 | $40 | 0.00% | +21 | New |
| True Wealth Design, LLC | 20 | $38 | 0.00% | +20 | New |
| IFP Advisors, Inc | 16 | $30 | 0.00% | 00.0% | Unchanged |
| CM Management, LLC | 0 | $0 | 0.00% | −310,000−100.0% | Sold out |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −158,394−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −156,871−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −52,754−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −51,000−100.0% | Sold out |
| Bleakley Financial Group, LLC | 0 | $0 | 0.00% | −39,993−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −24,072−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −22,588−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −13,887−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −10,536−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |